Delivery Order SPE2DR25D7005-SPE2DR26F3FBN
- Not listed
- The Defense Logistics Agency awarded a $1,127.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials, with a completion date of January 20, 2026. This non-set-aside, competitively awarded contract reflects standard pharmaceutical procurement practices for federal medical supply chain operations. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,690.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Atropine 1 mg/mL vials. This is a non-set-aside competitive award with an ultimate completion date of January 30, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $3,732.22 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This non-competitive delivery order utilizes firm fixed pricing and was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $4,213.36 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/ml vial supplies, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at $1,321.50 to AmerisourceBergen Drug Corp for the supply of Atropine 8 mg/20 mL vials. The contract, issued on January 8, 2026, with an ultimate completion date of January 9, 2026, was structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,312.85 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL). The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was competitively awarded with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a $12,393.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL in quantities of 10 units, with an ultimate completion date of December 29, 2025. This non-set-aside contract was competitively awarded on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.74 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes on January 28, 2026, with a completion date of January 29, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for a critical pharmaceutical commodity. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3FBNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,576.02 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials on January 29, 2026. The contract is competitively awarded with no set-aside designation and carries a firm fixed-price structure with a completion date of January 30, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's supply chain. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. The atropine supply serves emergency medical and anesthesia applications across the Defense Health Agency and other government healthcare systems, reflecting the contractor's essential role in maintaining pharmaceutical readiness for federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 1/28/26 |